Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 14:9:611-626.
doi: 10.2147/CMAR.S148856. eCollection 2017.

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study

Fan Dong #  1 , Yifan Shen #  1 , Fengbin Gao  2 , Tianyuan Xu  2 , Xianjin Wang  1 , Xiaohua Zhang  1 , Shan Zhong  1 , Minguang Zhang  1 , Shanwen Chen  1 , Zhoujun Shen  1
Affiliations

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study

Fan Dong et al. Cancer Manag Res. .

Abstract

Background: We aimed to evaluate the prognostic value of site-specific metastases in patients with metastatic bladder cancer and analyze the roles that surgeries play in the treatment of this malignancy.

Materials and methods: A population-based retrospective study using Surveillance, Epidemiology and End Results dataset was performed and metastatic bladder cancer patients were classified according to the sites of metastases (bone, brain, liver, lung and distant lymph nodes). Kaplan-Meier analysis with log-rank test was used for survival comparisons. Multivariate Cox regression model was employed to analyze the effect of distant metastatic sites on overall survival (OS) and cancer-specific survival (CSS).

Results: A total of 1862 patients with metastatic bladder cancer from 2010 to 2014 were identified. Bone, lung and distant lymph nodes were the most common metastatic sites. Patients with bone, brain, liver and lung involvement had worse OS and CSS compared to patients without the corresponding sites of metastases. Multivariate analysis showed that bone, brain, liver and lung metastases were independent prognostic factors for both OS and CSS, while distant node metastasis was not. Moreover, patients with a single metastatic site had more favorable OS (p<0.001) and CSS (p<0.001) than patients with multisite metastases. Among single-site metastatic patients, distant nodes and liver metastases represented the best and the worst prognosis, respectively. Moreover, radical cystectomy was an independent predictor for better OS and CSS, while in patients with liver metastasis and multiple metastatic sites, RC did not bring benefits. Besides, in patients with a single metastatic site, metastasectomy seemed to be associated with favorable OS (p=0.042), especially for patients with age <65 years (p=0.006) and for muscle-invasive bladder cancer patients (p=0.031).

Conclusion: Distant metastatic sites have differential impact on survival outcomes in patients with metastatic bladder cancer. Surgeries, including radical cystectomy and metastasectomy, might still lead to survival benefits for highly selected patients.

Keywords: Epidemiology and End Results; Surveillance; bladder cancer; metastasectomy; metastatic site; prognosis; radical cystectomy.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Venn diagram of the distribution of distant metastatic sites in the overall cohort.
Figure 2
Figure 2
Kaplan–Meier curves of overall survival and cancer-specific survival according to whether or not patients had bone (A, B), brain (C, D), liver (E, F), lung (G, H) and distant lymph node (I, J) metastases.
Figure 3
Figure 3
Kaplan–Meier curves of overall survival (A) and cancer-specific survival (B) according to the number of metastatic sites.
Figure 4
Figure 4
Kaplan–Meier curves of overall survival (A) and cancer-specific survival (B) according to the sites of metastases in patients with single metastatic site.
Figure 5
Figure 5
Kaplan–Meier curves of overall survival and cancer-specific survival according to whether or not radical cystectomy has been done for the overall cohort (A, B), in patients with single metastatic site (C, D) and in patients with multiple metastatic sites (E, F).
Figure 6
Figure 6
Kaplan–Meier curves of overall survival and cancer-specific survival according to whether or not radical cystectomy has been done for patients with bone-only (A, B), liver-only (C, D), lung-only (E, F) and distant node-only (G, H) metastases.
Figure 7
Figure 7
Kaplan–Meier curves of overall survival and cancer-specific survival according to whether or not metastasectomy has been done for all patients with single metastatic site (A, B), single metastatic patients with age <65 years (C, D), single metastatic female patients (E, F) and single metastatic patients with muscle-invasive bladder cancer (G, H).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dong F, Xu T, Shen Y, et al. Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure. Oncotarget. 2017;8(16):27547–27568. - PMC - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. - PubMed
    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. - PubMed
    1. Pruthi RS, Baldwin N, Bhalani V, Wallen EM. Conservative management of low risk superficial bladder tumors. J Urol. 2008;179(1):87–90. discussion 90. - PubMed
    1. Witjes JA, Compérat E, Cowan NC, et al. EAU- ESTRO-ESUR-SIOG Guidelines. Arnhem: EAU Guidelines Office; 2017. Muscle-invasive and metastatic bladder cancer; pp. 9–10.